X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare J.B.Chemicals with Aventis Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs SANOFI INDIA - Comparison Results

J.B.CHEMICALS    Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

SANOFI INDIA 
   Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS SANOFI INDIA J.B.CHEMICALS/
SANOFI INDIA
 
P/E (TTM) x 15.9 32.9 48.3% View Chart
P/BV x 2.5 6.3 40.1% View Chart
Dividend Yield % 0.2 1.4 10.7%  

Financials

 J.B.CHEMICALS   SANOFI INDIA
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-16
SANOFI INDIA
Dec-16
J.B.CHEMICALS/
SANOFI INDIA
5-Yr Chart
Click to enlarge
High Rs3184,560 7.0%   
Low Rs2004,400 4.5%   
Sales per share (Unadj.) Rs148.01,028.5 14.4%  
Earnings per share (Unadj.) Rs19.1129.0 14.8%  
Cash flow per share (Unadj.) Rs23.9186.0 12.9%  
Dividends per share (Unadj.) Rs0.5068.00 0.7%  
Dividend yield (eoy) %0.21.5 12.7%  
Book value per share (Unadj.) Rs128.9753.6 17.1%  
Shares outstanding (eoy) m84.8223.03 368.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.74.4 40.2%   
Avg P/E ratio x13.634.7 39.0%  
P/CF ratio (eoy) x10.824.1 44.9%  
Price / Book Value ratio x2.05.9 33.8%  
Dividend payout %2.652.7 5.0%   
Avg Mkt Cap Rs m21,951103,174 21.3%   
No. of employees `0002.73.6 75.5%   
Total wages/salary Rs m1,8413,592 51.3%   
Avg. sales/employee Rs Th4,590.96,537.7 70.2%   
Avg. wages/employee Rs Th673.4991.4 67.9%   
Avg. net profit/employee Rs Th592.1819.8 72.2%   
INCOME DATA
Net Sales Rs m12,55123,686 53.0%  
Other income Rs m542708 76.5%   
Total revenues Rs m13,09324,394 53.7%   
Gross profit Rs m2,0555,281 38.9%  
Depreciation Rs m4121,313 31.4%   
Interest Rs m9615 638.0%   
Profit before tax Rs m2,0884,661 44.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m4691,691 27.7%   
Profit after tax Rs m1,6192,970 54.5%  
Gross profit margin %16.422.3 73.4%  
Effective tax rate %22.536.3 61.9%   
Net profit margin %12.912.5 102.9%  
BALANCE SHEET DATA
Current assets Rs m7,77815,673 49.6%   
Current liabilities Rs m4,3586,678 65.3%   
Net working cap to sales %27.238.0 71.7%  
Current ratio x1.82.3 76.0%  
Inventory Days Days5576 71.9%  
Debtors Days Days8022 358.6%  
Net fixed assets Rs m5,7138,098 70.5%   
Share capital Rs m170230 73.6%   
"Free" reserves Rs m10,54717,088 61.7%   
Net worth Rs m10,93717,356 63.0%   
Long term debt Rs m00-   
Total assets Rs m15,57425,400 61.3%  
Interest coverage x22.8311.7 7.3%   
Debt to equity ratio x00-  
Sales to assets ratio x0.80.9 86.4%   
Return on assets %11.011.8 93.7%  
Return on equity %14.817.1 86.5%  
Return on capital %20.026.9 74.1%  
Exports to sales %48.724.5 198.9%   
Imports to sales %7.128.0 25.3%   
Exports (fob) Rs m6,1155,801 105.4%   
Imports (cif) Rs m8896,627 13.4%   
Fx inflow Rs m6,1697,145 86.3%   
Fx outflow Rs m1,2856,846 18.8%   
Net fx Rs m4,884299 1,633.4%   
CASH FLOW
From Operations Rs m1,3973,226 43.3%  
From Investments Rs m-320-1,555 20.6%  
From Financial Activity Rs m-1,196-1,818 65.8%  
Net Cashflow Rs m-102-147 69.6%  

Share Holding

Indian Promoters % 55.4 0.0 -  
Foreign collaborators % 0.3 60.4 0.5%  
Indian inst/Mut Fund % 3.4 14.4 23.5%  
FIIs % 3.9 14.6 26.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 10.5 352.4%  
Shareholders   30,437 15,184 200.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   CIPLA  PFIZER  ALEMBIC PHARMA  ORCHID PHARMA LTD  NOVARTIS  

Compare J.B.CHEMICALS With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex, Nifty Close at Record Highs; Bank & Realty Stocks Rally(Closing)

After opening the day marginally higher, Indian share markets extended gains in the afternoon session after the government decided to cut tax rates on certain products and services.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Jan 19, 2018 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS 5-YR ANALYSIS

COMPARE J.B.CHEMICALS WITH

MARKET STATS